Currently, there are 61.00M common shares owned by the public and among those 59.56M shares have been available to trade.
The company’s stock has a 5-day price change of 0.57% and 7.15% over the past three months. MMS shares are trading 10.02% year to date (YTD), with the 12-month market performance up to 14.45% higher. It has a 12-month low price of $72.39 and touched a high of $93.97 over the same period. MMS has an average intraday trading volume of 369.87K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.18%, 3.62%, and 9.17% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Maximus Inc. (NYSE: MMS) shares accounts for 100.76% of the company’s 61.00M shares outstanding.
It has a market capitalization of $5.55B and a beta (3y monthly) value of 0.76. The stock’s trailing 12-month PE ratio is 19.34, while the earnings-per-share (ttm) stands at $4.77. The company has a PEG of 1.55 and a Quick Ratio of 1.59 with the debt-to-equity ratio at 0.71. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.45% over the week and 1.93% over the month.
Earnings per share for the fiscal year are expected to increase by 59.97%, and -2.77% over the next financial year. EPS should grow at an annualized rate of 12.50% over the next five years, compared to -4.69% over the past 5-year period.
Stifel coverage for the Maximus Inc. (MMS) stock in a research note released on August 18, 2023 offered a Buy rating with a price target of $102. Raymond James was of a view on June 28, 2021 that the stock is Outperform, while Raymond James gave the stock Strong Buy rating on July 08, 2020, issuing a price target of $90. KeyBanc Capital Markets on their part issued Overweight rating on June 24, 2020.
